The effect of batroxobin on atherosclerosis.
- Author:
Juan HUANG
1
;
Dong ZHOU
;
Linyu TIAN
;
Hongtao WU
;
Jie ZHANG
;
Shangfu ZHANG
;
Huaiqing CHEN
Author Information
1. Department of Neurology, West China Hospital of Sichuan University, Chengdu 610041.
- Publication Type:Journal Article
- MeSH:
Animals;
Arteriosclerosis;
drug therapy;
pathology;
Batroxobin;
therapeutic use;
Disease Models, Animal;
Female;
Fibrinolytic Agents;
therapeutic use;
Male;
Rabbits
- From:
Journal of Biomedical Engineering
2003;20(2):197-201
- CountryChina
- Language:Chinese
-
Abstract:
To study the effect of batroxobin(DF-521) on atherosclerosis, we divided 50 Japanese big ear rabbits into control group and high-lipid group. After the atherosclerosis model was successfully established, the high-lipid rabbits were divided into 3 groups(placebo group, treatment group 1 and treatment group 2). Batroxobin was injected in the treatment groups, and saline was injected in placebo group and control group. Getting the aorta before, inter and after treatment, dyeing the lipid, endothelium, smooth muscle, collagen fibers of the vascular plaque(the elastic fibers are of autofluorescence), we observed them with the light microscope and laser scanning confocal microscope. From the results, we found that the atherosclerotic plaque in the treatment groups, tended to be static four weeks later, but there was no obvious difference between treatment group 1 and treatment group 2. These implied that batroxobin possessed the action of stabilizing the atherosclerotic plaque, but the dosage-effect was not clear and the principle needed more study.
